What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protective protein found in human gastric juice. It has been studied extensively in animal models since the 1990s, primarily for its effects on tissue repair, gut health, and inflammation.
The compound's name reflects its origin: it was isolated from a "body protection compound" in gastric juice that appeared to play a role in gastrointestinal mucosal integrity. Researchers synthesized a stable fragment (the 15-amino-acid sequence designated BPC-157) for use in preclinical studies.
Research Status
BPC-157 is studied primarily in animal models. As of 2025, there are no completed, published randomized controlled trials in humans. The evidence base consists of:
- Over 100 peer-reviewed animal studies
- Several in vitro (cell culture) studies
- Limited case reports and observational data
- No FDA approval for any indication
This is important context. When we say "research suggests" throughout this guide, we mean animal and in vitro research unless specifically noted otherwise.
What Has Been Studied?
Tissue Repair and Recovery
The most extensive body of research on BPC-157 concerns its effects on tissue repair in animal models. Studies have examined:
- Tendon healing: Multiple rat studies suggest accelerated tendon-to-bone healing, with increased collagen organization and mechanical strength
- Muscle repair: Animal models of muscle crush injury showed faster functional recovery with BPC-157 administration
- Bone healing: Limited evidence suggests possible effects on bone fracture repair in rat models
- Ligament repair: Studies in rat models of MCL transection showed improved healing parameters
Gastrointestinal Effects
Given its origin in gastric juice, GI research is extensive:
- Gastric ulcer protection: Multiple animal studies demonstrate protective effects against various ulcer-inducing agents (NSAIDs, alcohol, stress)
- Inflammatory bowel models: Rat studies suggest reduction in inflammation markers in experimentally-induced colitis
- Gut-brain axis: Some animal research suggests effects on serotonin and dopamine systems, potentially mediated through the gut-brain axis
Mechanism of Action
The exact mechanism is not fully elucidated, but research suggests BPC-157 may:
- Promote angiogenesis (new blood vessel formation) via VEGF pathways
- Modulate nitric oxide (NO) signaling
- Interact with the dopaminergic system
- Influence growth factor expression (EGF, FGF)
- Affect collagen formation and organization
Key Research Limitations
- No human clinical trials: The entire evidence base is preclinical
- Dosing uncertainty: Animal doses don't translate directly to human equivalents
- Publication bias: Positive results are more likely to be published
- Single research group: A significant portion of studies come from one laboratory group (Sikiric et al.)
- Long-term safety: No long-term safety data in any species
Molecular Properties
| Property | Value |
|---|---|
| Molecular Weight | 1,419.5 g/mol |
| CAS Number | 137525-51-0 |
| Sequence | 15 amino acids |
| Half-Life | ~4 hours (subcutaneous, estimated) |
| Storage | 2-8°C reconstituted |
| Research Status | Animal models |
Where to Research Further
The primary literature on BPC-157 is indexed on PubMed. We recommend starting with review articles that synthesize the available animal data before diving into individual studies.
Important: BPC-157 is a research compound. It is not approved by the FDA for any medical use. All discussion in this article is for research and educational purposes only. Consult a qualified healthcare provider before considering any research protocol.
Want a personalized protocol?
Take the assessment and we'll match you to the right research stack based on your goals.
Start your assessment →